Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf M Mesters

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Journal of Cell Science|April 17, 2002
The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet-derived and basic fibroblast growth factors in human vascular smooth muscle cellsTeresa Padró, Rolf M Mesters, Berno Dankbar, et al.
Haematologica|September 8, 2006
Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemiaChristoph Schliemann, Ralf Bieker, Teresa Padro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculatureTorsten Kessler, Ralf Bieker, Teresa Padró, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Prognostic relevance of increased angiogenesis in osteosarcomaMichael Kreuter, Ralf Bieker, Stefan S Bielack, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2006
Clinical significance of Vascular Endothelial Growth Factor-A expression in Ewing's sarcomaMichael Kreuter, Michael Paulussen, Johannes Boeckeler, et al.
International Journal of Oncology|September 18, 2004
Influence of keratinocyte growth factor on clonal growth of epithelial tumor cells, lymphoma and leukemia cells and on sensitivity of tumor cells towards 5-fluorouracil in vitroElisabeth Oelmann, Susan Haghgu, Emma Kulimova, et al.
Cancer Research|November 13, 2003
Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemiaRalf Bieker, Teresa Padró, Julia Kramer, et al.
American Journal of Hematology|September 8, 2011
Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in Burkitt's and primary mediastinal large B-cell lymphomaMichele Pohlen, Hans U Gerth, Ruediger Liersch, et al.
Lung Cancer (Amsterdam, Netherlands)|October 28, 2006
Prognostic significance of vessel architecture and vascular stability in non-small cell lung cancerNiels Reinmuth, Elisabeth Piegelbrock, Miriam Raedel, et al.
Blood|January 25, 2002
Efficacy and safety of thalidomide in patients with acute myeloid leukemiaMartin B Steins, Teresa Padró, Ralf Bieker, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Journal of Cell Science|April 17, 2002
The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet-derived and basic fibroblast growth factors in human vascular smooth muscle cellsTeresa Padró, Rolf M Mesters, Berno Dankbar, et al.
Haematologica|September 8, 2006
Expression of angiopoietins and their receptor Tie2 in the bone marrow of patients with acute myeloid leukemiaChristoph Schliemann, Ralf Bieker, Teresa Padro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculatureTorsten Kessler, Ralf Bieker, Teresa Padró, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Prognostic relevance of increased angiogenesis in osteosarcomaMichael Kreuter, Ralf Bieker, Stefan S Bielack, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2006
Clinical significance of Vascular Endothelial Growth Factor-A expression in Ewing's sarcomaMichael Kreuter, Michael Paulussen, Johannes Boeckeler, et al.
International Journal of Oncology|September 18, 2004
Influence of keratinocyte growth factor on clonal growth of epithelial tumor cells, lymphoma and leukemia cells and on sensitivity of tumor cells towards 5-fluorouracil in vitroElisabeth Oelmann, Susan Haghgu, Emma Kulimova, et al.
Cancer Research|November 13, 2003
Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemiaRalf Bieker, Teresa Padró, Julia Kramer, et al.
American Journal of Hematology|September 8, 2011
Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in Burkitt's and primary mediastinal large B-cell lymphomaMichele Pohlen, Hans U Gerth, Ruediger Liersch, et al.
Lung Cancer (Amsterdam, Netherlands)|October 28, 2006
Prognostic significance of vessel architecture and vascular stability in non-small cell lung cancerNiels Reinmuth, Elisabeth Piegelbrock, Miriam Raedel, et al.
Blood|January 25, 2002
Efficacy and safety of thalidomide in patients with acute myeloid leukemiaMartin B Steins, Teresa Padró, Ralf Bieker, et al.
Pageof 7